Jpmorgan Chase & CO Koru Medical Systems, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Koru Medical Systems, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 617 shares of KRMD stock, worth $2,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
617
Previous 2,553
75.83%
Holding current value
$2,480
Previous $6,000
83.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding KRMD
# of Institutions
57Shares Held
12.8MCall Options Held
3KPut Options Held
3.8K-
First Light Asset Management, LLC Edina, MN5.6MShares$22.5 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$7.17 Million0.0% of portfolio
-
Meros Investment Management, LP Dallas, TX805KShares$3.24 Million1.02% of portfolio
-
Albion Financial Group668KShares$2.68 Million0.13% of portfolio
-
Rbf Capital, LLC San Francisco, CA521KShares$2.1 Million0.07% of portfolio
About KORU Medical Systems, Inc.
- Ticker KRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 45,033,100
- Market Cap $181M
- Description
- KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneou...